Dyne Therapeutics, Inc.

Q1 2026 13F Holders

Symbol
DYN
CUSIP
26818M108
Type
Equity
Class
COM
Num filings
238
Total reported value, excl. options
$3.41 B
Manager Report Date Value ($000) Shares Option Type